SCHEMBL24577224

SCHEMBL24577224

Cc1cnn2cc(-c3cnn(C)c3C)sc12

nearest known ligand 0.36

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CYP11B2 P19099 1/20 0.36
▸ CREBBP Q92793 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24578161 0.80 RAB9A (0.36) CYP11B2CREBBP
SCHEMBL24577706 0.80 KDM4E (0.43) CYP11B2CREBBP
SCHEMBL24577371 0.77 COMT (0.39) —
SCHEMBL24577152 0.76 CREBBP (0.32) CREBBP
SCHEMBL24577223 0.76 MAPT (0.40) —
SCHEMBL24577874 0.73 FLT3 (0.38) CREBBP
SCHEMBL24578878 0.70 KDR (0.38) —
SCHEMBL24578525 0.70 BRAF (0.30) —
SCHEMBL24577085 0.67 KIT (0.39) —
SCHEMBL21240977 0.66 CYP11B2 (0.42) CYP11B2CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022136509-A1 PYRAZOLOTHIAZOLE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2022-06-30 — — WO disclosed
Send feedback